帕金森病中的睡眠障碍:通过系统审查和元分析评估药理疗法
Jingqi Li1,2, Runtang Zhou1,2, Jialin Deng1
1Department of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
BMC neurology
|December 15, 2025
概括
药物治疗有效改善过度白天嗜睡 (EDS) 和帕金森病失眠.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 睡眠障碍是帕金森病 (PD) 中普遍存在的非运动性症状,显著影响患者的生活质量.
- 对于PD患者睡眠障碍的药理干预措施的有效性仍然是正在进行的研究和辩论的主题.
研究的目的:
- 系统地审查和对帕金森病患者各种睡眠障碍的药理疗法的有效性进行元分析.
主要方法:
- 在主要数据库 (PubMed,Embase,Web of Science,Cochrane Library) 进行了全面的搜索,截至2025年1月.
- 包括随机对照试验 (RCT),调查PD患者睡眠障碍的药理干预措施.
- 分析使用了加权平均差异 (WMD) 和标准化平均差异 (SMD) 与随机效应模型;证据的确定性使用GRADE.评估.
主要成果:
- 药理干预措施在改善PD患者的过度白天嗜睡 (EDS) (SMD: -0.36) 和失眠 (SMD: -0.53) 中表现出显著的有效性.
- 在快速眼动睡眠行为障碍 (RBD) (SMD: -0.19) 的药理管理中没有观察到显著的益处.
- 在包括的研究中,证据的确定性从非常低到中等不等.
结论:
- 药物治疗对EDS和帕金森病的失眠是有效的.
- 通过当前的药物选择来管理快速眼动睡眠行为障碍 (RBD) 仍然是一个挑战.
- 需要进一步进行高质量的研究,以解决PD中RBD的药理治疗问题.
相关概念视频
Parkinson's Disease: Treatment
940
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
Management of Insomnia
499
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
499
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
477
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
477
REM Sleep Behavior Disorder
1.3K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
1.3K
Narcolepsy
463
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
463


